<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Experimental Drugs Show Promise for Containing Ebola Outbreak
Image Overlay - Experimental Drugs Show Promise for Containing Ebola Outbreak

Experimental Drugs Show Promise for Containing Ebola Outbreak

August 28, 2019

Experimental Drugs Show Promise for Containing Ebola Outbreak

Two experimental Ebola treatments — Regeneron's REGN-EB3 and another antibody-based therapy called mAb114 — are advancing to an extension phase of a large clinical trial after an it was determined they offer significantly better survival rates than the standard of care. Yourway is pleased with this clinical progress, having assisted Regeneron in rapidly delivering experimental Ebola drugs to infected patients in the Congo during the 2018 outbreak.

 Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?